Le Lézard
Classified in: Ebola virus
Subject: SVY

Global Blood Typing, Grouping and Infectious Disease Screening Market 2016-2018 & 2026


DUBLIN, June 21, 2018 /PRNewswire/ --

The "Global Blood Typing, Grouping and Infectious Disease Screening Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global blood typing, grouping and infectious disease screening market is projected to reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026.

The factors contributing to the market growth includes increase in disposable income, rising population, growing awareness regarding blood donations and blood products. According to the Centers for Disease Control and Prevention, the cases of syphilis, a disease caused by Treponema pallidum, has increased by 17.6% in 2016 accounting for 8.7 cases per 100,000 population in the United States. Furthermore, the growing rate of infections catalyze the market growth.

According to the HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary's Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. The global blood typing, grouping and infectious disease screening market is segmented based on the test type, product type, infectious agent, and geography.

Based on the test type, the global market is segmented into ABO grouping, immunoassay screening and nucleic acid testing (NAT). In 2017, the market was dominated by the ABO grouping segment owing to the growing demand for blood & blood products, growing number of trauma cases and increasing usage of ABO blood grouping across other industries. Furthermore, NAT segment is identified as the fastest growing segment during the forecast period from 2018 to 2026. Based on the product type, the global market is segmented into kits, consumables and instruments. In 2017, consumables segment led the global market. Based on the infectious agent, the cytomegalovirus (CMV) led the market in 2017 owing to huge burden of infection cases.

Based the geographical segmentation, in 2017, North America led the global market with over 34% of the share, in terms of value. The supremacy of North America is attributed to the awareness among public regarding blood donations and infectious diseases. Furthermore, the treatment cost is higher compared to other parts of the world thereby making NA contribute majorly by value as compared to other regions. Asia Pacific is identified as the fastest growing region during the forecast period followed by the Latin America. Developing countries in these regions are the most potential markets such as India and Brazil that offers huge opportunities to the manufacturers.

The market is highly fragmented due to presence of several local and international manufacturers. No clear market leader is identified and the shares are distributed among the key players present in the market. The international players accounted more share than local players due to high market penetration, vast geographical outreach and diverse product portfolio.

Key Topics Covered:

Chapter 1. Preface

1.1. Report Description


1.1.1. Purpose of the Report


1.1.2. Target Audience


1.1.3. USP and Key Offerings


1.2. Market Segmentation


1.3. Research Scope


1.4. Research Methodology

Chapter 2. Executive Summary




2.1. Global Blood Typing, Grouping and Infectious Disease Screening Market Portraiture


2.2. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2017 (US$ Mn)


2.3. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2017 (US$ Mn)


2.4. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2017 (US$ Mn)


2.5. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Blood Typing, Grouping and Infectious Disease Screening Market: Dynamics and Future Outlook




3.1. Overview


3.2. Market Dynamics


3.2.1. Drivers


3.2.1.1. Growing Incidence of Viral Infections


3.2.2. Challenges


3.2.3. Opportunities


3.3. Attractive Investment Proposition, by Geography, 2017


3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)




4.1. Overview


4.2. ABO Grouping


4.3. Immunoassay Screening


4.4. Nucleic Acid Testing (NAT)

Chapter 5. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)




5.1. Overview


5.2. Instruments


5.3. Consumables


5.4. Kits

Chapter 6. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)




6.1. Overview


6.2. Hepatitis B Virus (HBV)


6.3. Hepatitis C Virus (HCV)


6.4. Human Immunodeficiency Virus (HIV)


6.5. Human T-Lymphotropic Virus (HTLV)


6.6. Treponema pallidum (T. palladium)


6.7. Trypanosoma cruzi (T. cruzi)


6.8. West Nile Virus (WNV)


6.9. Cytomegalovirus (CMV)


6.10. Other Agents (Parvovirus, Ebola Virus, etc.)

Chapter 7. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2016 - 2026 (US$ Mn)

Chapter 8. Company Profiles






For more information about this report visit https://www.researchandmarkets.com/research/sjqll7/global_blood?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

22 jan 2019
About this marketDevelopment of 5G networks to drive growth in the market. There has been an increasing focus on the development of 5G technology across the globe. 5G networks are an incumbent technology that supports network speeds, which are over...

21 jan 2019
The Constitutional court in DRC has confirmed the presidential election victory of Felix Tshisekedi. Tshisekedi stated that the court's decision to reject claims of electoral fraud and declare him president was a victory for the entire country...

21 jan 2019
The SKF Group will publish its full year results on 29 January 2019 and welcomes investors, analysts and members of the media to take part in a conference call, which will be held in English, at 14:00 (Swedish Time), 13:00 (UK Time). To join the...

21 jan 2019
Fourth quarter 2018 Continuing operations   Order intake 25,627 million SEK Revenues 25,968 million SEK Operating profit 4,170 million SEK Operating margin 16.1% Adjusted operating profit 4,700 million SEKAdjusted operating margin 18.1%Profit after...

18 jan 2019
The Council of State and Territorial Epidemiologists (CSTE) has announced the approval of an interim position statement for nonfatal opioid overdose case definition for standardized public health surveillance. Coinciding with the recent National...

18 jan 2019
Castellum has completed an exchange transaction with Fastighetsaktiebolaget Lilium, wherein Castellum will acquire six properties in Linköping, and sell twenty properties in Sundsvall. Vacancy/Occupancy dates occur March 1, 2019. "Linköping is an...



News published on 21 june 2018 at 10:00 and distributed by: